SILK
Silk Road Medical Inc (SILK)
$39.451.31%▲
Key Stats
$37.63
Day's Range
$39.56
$27.21
52-Week Range
$67.49
| Returns | |
| 1 month return | 8.41% |
| 3 month return | 9.38% |
| 1 year return | 16.37% |
| 5 year return | 7.63% |
Company Information
Silk Road Medical, Inc.,is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company's flagship procedure, TransCarotid Artery Revascularization (TCAR), is clinically proven to treat blockages in the carotid artery at risk of causing a stroke.
| Organization | Silk Road Medical Inc |
| CEO | Erica Rogers |
| Industry | Medical Specialties |
Analyst Recommendation
based on 13 analysts ratings
Buy
76%
Buy
23%
Hold
0%
Sell
Based on 13 Wall street analysts offering stock ratings for Silk Road Medical Inc(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 14.02%Current
$38.94
Target
$44.4
Recommendation Trend
Based on 13 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 10 | 10 | 10 |
| Hold | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 |
| Consensus | BUY | BUY | BUY |
Company Financials
Highlights
| Market Capitalization | 1.3B |
| Book Value | 2.27 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0 |
| Earnings Share | -1.44 |
| Wall Street Target Price | 52.5 |
Valuation
| Trailing PE | 0.0 |
| Forward PE | 0.0 |
| Price/Sales (ttm) | 12.91 |
| Price/Book (mrq) | 16.72 |
| Enterprise Value | 1.3B |
| Enterprise Value/Revenue | 12.46 |
| Enterprise Value/Ebitda | 0.0 |
Technicals
| Beta | 1.58 |
| 50 Day MA | 38.16 |
| 200 Day MA | 45.6 |
Institutional Holdings
Wasatch Advisors Inc.
11.64%
AllianceBernstein L.P.
10.67%
Vanguard Group Inc
8.62%
Capital World Investors
7.95%
BlackRock Inc
7.2%
Deerfield Management Co
6.13%
